hiPSC-derived cardiac and neuronal cell lines for drug screening and disease modelling
CompanyNcardia, Leiden, Netherlands
The company Ncardia specializes in the differentiation and development of human induced pluripotent stem cells (hiPSCs) into complex microtissues/microorgans. Ncardia currently offers a heart and a nerve cell line and is working on the serial development of other tissue types. The three-dimensional models can be tailored to the researchers' wishes in terms of their phenotypic characteristics. The cells are suitable for modelling various diseases and can be produced in large batches with low variability, enabling the development of assay-based high-throughput screenings. In addition to the two well-established cell lines, Ncardia offers the development of personalized models that are derived directly from samples from the patients being treated. This allows targeted drug research to be carried out. The company's modelling and screening technologies can help save time and costs when conducting drug trials and also promise further advances in the field of personalized medicine.
Integrated drug discovery services from Ncardia
support@ncardia.com
Added on: 10-04-2023
[1] https://www.ncardia.com/discovery-services[2] https://www.ncardia.com/discovery-services/modeling
